MISSISSAUGA, ON, Feb. 16, 2017 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) today announced it will host a conference call
Q4 AND YEAR-END 2016 CONFERENCE CALL
WHEN: Thursday, March 2, 2017 at 8:30AM ET
CONFERENCE CALL/WEBCAST: You can join the call
About Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX:CPH) is a growing specialty pharmaceutical dermatology company, with a robust and diversified portfolio of commercial and early to late-stage products. Through multiple transactions, Cipher has built its U.S. commercial presence, expanded its Canadian dermatology franchise and broadened its pipeline. Cipher is well-capitalized to drive long-term, sustained earnings growth by leveraging its proven clinical development capabilities and efficient commercial execution. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
Subscribe to our Free Newsletters!
Sarcoma, is a cancer that may arise from several soft-tissues or bone. Treatment in early stages is ...
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...View All